121 related articles for article (PubMed ID: 6219982)
1. Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins.
Chattopadhyay B; Hall I; Curnow SR
J Antimicrob Chemother; 1983 Feb; 11(2):200-1. PubMed ID: 6219982
[No Abstract] [Full Text] [Related]
2. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
Fass RJ
Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
4. The in vitro activity of ceftazidime against resistant clinical isolates.
Van Landuyt HW; Denolf BL; Pyckavet M; Lambert AM
Infection; 1983; 11 Suppl 1():S23-7. PubMed ID: 6299967
[TBL] [Abstract][Full Text] [Related]
5. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
[TBL] [Abstract][Full Text] [Related]
6. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Cynamon MH; Granato PA
Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
10. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
Leigh DA; Marriner J
J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
[TBL] [Abstract][Full Text] [Related]
12. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
Verbist L
Antimicrob Agents Chemother; 1981 Mar; 19(3):407-13. PubMed ID: 6972728
[TBL] [Abstract][Full Text] [Related]
14. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
15. The activity in vitro of ceftazidime (GR 20263) and moxalactam (LY 127935) against Gram-negative bacteria from hospital patients.
Pedler SJ
J Antimicrob Chemother; 1981 Nov; 8(5):417-20. PubMed ID: 6459317
[No Abstract] [Full Text] [Related]
16. [Moxalactam: preclinical evaluation].
Chabbert YA
Sem Hop; 1983 Jun; 59(26):1943-6. PubMed ID: 6310782
[No Abstract] [Full Text] [Related]
17. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Dornbusch K; Adamsson L; Gezelius L; Hallander H
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
[No Abstract] [Full Text] [Related]
18. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
[No Abstract] [Full Text] [Related]
20. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
